Gene · 5236
PGM1: phosphoglucomutase 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. PGM1: phosphoglucomutase 1. Genes, record 5236. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/5236
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P36871 | Phosphoglucomutase-1 | 562 | 16 | Ensembl, GeneID, HGNC |
Source UniProt
Patents50
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026067851 A | 2026-04-21 | 230 | P36871 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 57824 | P36871 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 8892 | P36871 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 8892 | P36871 | Espacenet |
| JP 2023521663 A | 2023-05-25 | 229 | P36871 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 63089 | P36871 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 166060 | P36871 | Espacenet |
| JP 2021530985 A | 2021-11-18 | 337 | P36871 | Espacenet |
| WO 2021202604 A1 | 2021-10-07 | 230 | P36871 | Espacenet |
| US 10718785 B2 | 2020-07-21 | 1 | P36871 | Espacenet |
1 to 10 of 50
See all 50 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants886
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | PGM1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 17 | 2025 |
| R01DK099551 | New Congenital Disorders of Glycosylation: Therapy and Models | 6 | 2025 |
| U54GM104940 | Louisiana Clinical and Translational Science Center | 6 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 4 | 2025 |
| T32GM008638 | Medical Genetics Research Training Grant | 4 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 4 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 2 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 2 | 2025 |
| P30CA015704 | Cancer Center Support Grant | 2 | 2025 |
| P30CA016359 | Cancer Center Support Grant | 2 | 2025 |
1 to 10 of 886Source NIH's project files
See all 886 nih grantsPapers2,310
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development and internal validation of a six-gene prognostic model based on galactose metabolism for overall survival in lung adenocarcinoma. | Transl Cancer Res | 2026 | 42724461 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblasts Promote Glucose Metabolic Reprogramming and Progression of Triple-Negative Breast Cancer via Exosomal circFAD104-Mediated Intercellular Communication. | Adv Sci (Weinh) | 2026 | 42667179 | PubTator, text mining | PubMed |
| Glycogen storage disease type XIV in the Middle East and North Africa region: A case report. | World J Clin Pediatr | 2026 | 42625953 | PubTator, text mining | PubMed |
| Metabolic buffering restricts phenotype switching in melanoma. | EMBO J | 2026 | 42458060 | PubTator, text mining | PubMed |
| Structural insights into mutated human phosphoglucomutase 1 (PGM1) using computational approaches. | J Biomol Struct Dyn | 2026 | 42412886 | PubTator, text mining | PubMed |
| [Erdheim-Chester disease: a clinicopathological analysis of 16 cases]. | Zhonghua Bing Li Xue Za Zhi | 2026 | 42103616 | PubTator, text mining | PubMed |
| Network-Based Prediction of Oligodendroglioma Driver Gene Candidates within the Region of the 1p/19q Co-deletion Utilizing Single-Cell Transcriptomes. | Comput Struct Biotechnol J | 2026 | 42088850 | PubTator, text mining | PubMed |
| Genome-wide association study reveals genetic loci associated with body shape related traits in Takifugu bimaculatus. | Comp Biochem Physiol Part D Genomics Proteomics | 2026 | 41934866 | PubTator, text mining | PubMed |
| Serum presepsin level reflects macrophage activation and hemophagocytosis in bone marrow. | PLoS One | 2026 | 41920837 | PubTator, text mining | PubMed |
| The Downregulation of Type 1 Diabetes Susceptibility Gene PGM1 Induces Metabolic Imbalance and Stress in Pancreatic β-Cells. | Diabetes | 2026 | 41915415 | PubTator, text mining | PubMed |
1 to 10 of 2,310
See all 2,310 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/5236
GET https://conductscience.org/api/genes/v1/5236/patents?page=2